Privium Fund Management B.V.
In its 13F for Q3 2025 (holdings as of September 30, 2025, filed November 4, 2025), Privium Fund Management B.V. reported 59 stock positions worth $556.3 million. Its top holding was Tesla (TSLA) at 19.5% of the portfolio, followed by Spotify Technology (SPOT, 11.9%) and Shopify Class A (SHOP, 11.1%). Compared with Q2 2025, it opened 8 new positions, sold out of 4, added to 21 and reduced 16. The biggest buy was Tesla (TSLA, shares +1%) and the biggest sale Spotify Technology (SPOT, shares −17%).
- Most Recent 13F
- Q2 2026
- Location
- AMSTERDAM, P7
- CIK
- 0001795097
- Portfolio Value
- $556.3M (Q3 2025)
- SEC Filing
- 0001754960-25-000748 ↗ filed Nov 4, 2025
Holdings Value
Holdings 59 stocks · $556.3M
| TSLA Tesla Inc. | 19.51% | 244,000 | $108.5M | Add +0.8% |
| SPOT Spotify Technology SA | 11.92% | 95,000 | $66.3M | Reduce -16.7% |
| SHOP Shopify Inc. Class A | 11.09% | 415,000 | $61.7M | Reduce -3.5% |
| PLTR Palantir Technologies Inc. Class A | 6.56% | 200,000 | $36.5M | Reduce -42.9% |
| AMZN Amazon.com Inc. | 5.88% | 149,000 | $32.7M | No change |
| SE Sea Ltd.-ADR | 5.14% | 160,000 | $28.6M | Reduce -23.8% |
| COIN Coinbase Global Inc. Class A | 4.79% | 79,000 | $26.7M | Add +12.9% |
| QURE Uniqure NV | 4.05% | 386,000 | $22.5M | Reduce -13.7% |
| ARWR Arrowhead Pharmaceuticals Inc. | 2.94% | 473,951 | $16.3M | Reduce -22.6% |
| IONS Ionis Pharmaceuticals Inc. | 2.93% | 248,894 | $16.3M | Reduce -7.0% |
| NVDA Nvidia Corp. | 2.72% | 81,000 | $15.1M | No change |
| PRQR Proqr Therapeutics NV | 1.91% | 4,998,287 | $10.6M | Add +0.0% |
| AMD Advanced Micro Devices | 1.75% | 60,000 | $9.7M | New |
| RARE Ultragenyx Pharmaceutical Inc. | 1.57% | 289,804 | $8.7M | Add +14.4% |
| LMND Lemonade Inc. | 1.40% | 145,000 | $7.8M | New |
| BIIB Biogen Inc. | 1.31% | 51,925 | $7.3M | Add +153.3% |
| AXSM Axsome Therapeutics Inc. | 1.15% | 52,732 | $6.4M | No change |
| IREN Iren Ltd. filed as IREN LIMITED | 1.10% | 130,000 | $6.1M | New |
| ARQT Arcutis Biotherapeutics Inc. | 1.04% | 305,972 | $5.8M | Reduce -11.2% |
| MRK Merck & Co. Inc. | 0.97% | 64,393 | $5.4M | Add +9.0% |
| ASTS Ast Spacemobile Inc. | 0.97% | 110,000 | $5.4M | New |
| ZLAB Zai Lab Ltd.-ADR | 0.81% | 132,189 | $4.5M | No change |
| URGN Urogen Pharma Ltd. | 0.71% | 196,622 | $3.9M | Add +82.7% |
| VRTX Vertex Pharmaceuticals Inc. | 0.58% | 8,300 | $3.3M | No change |
| CRSP Crispr Therapeutics AG | 0.47% | 40,000 | $2.6M | Reduce -10.5% |
| ABVX Abivax SA-ADR | 0.46% | 30,412 | $2.6M | New |
| RNAM Avidity Biosciences Inc. | 0.42% | 53,000 | $2.3M | Add +15.2% |
| HIMS Hims & Hers Health Inc. | 0.41% | 40,000 | $2.3M | Add +81.8% |
| KRYS Krystal Biotech Inc. | 0.39% | 12,170 | $2.1M | Add +30.6% |
| ABEV Ambev SA-ADR | 0.36% | 897,134 | $2.0M | Add +12.7% |
| ROIV Roivant Sciences Ltd. | 0.35% | 126,923 | $1.9M | No change |
| BNTX Biontech SE-ADR | 0.34% | 19,000 | $1.9M | Add +72.9% |
| FDMT 4D Molecular Therapeutics Inc. | 0.31% | 197,458 | $1.7M | No change |
| ACAD Acadia Pharmaceuticals Inc. | 0.27% | 70,400 | $1.5M | Reduce -52.6% |
| BEAM Beam Therapeutics Inc. | 0.27% | 61,000 | $1.5M | New |
| RCKT Rocket Pharmaceuticals Inc. | 0.25% | 432,760 | $1.4M | No change |
| MGTX Meiragtx Holdings PLC | 0.24% | 163,000 | $1.3M | No change |
| LXEO Lexeo Therapeutics Inc. | 0.23% | 192,356 | $1.3M | Add +7.8% |
| WVE Wave Life Sciences Ltd. | 0.22% | 170,000 | $1.2M | Add +25.4% |
| MRNA Moderna Inc. | 0.22% | 47,000 | $1.2M | Reduce -54.6% |
| SA Seabridge Gold Inc. | 0.21% | 48,474 | $1.2M | Add +10.0% |
| PFE Pfizer Inc. | 0.17% | 37,750 | $962K | Add +1.9% |
| ALXO Alx Oncology Holdings Inc. | 0.17% | 509,059 | $932K | No change |
| VZLA Vizsla Silver Corp. | 0.16% | 204,654 | $884K | Reduce -18.4% |
| NOV Nov Inc. | 0.15% | 63,876 | $846K | No change |
| PAAS Pan American Silver Corp. | 0.13% | 18,531 | $718K | Reduce -37.7% |
| URNM Sprott Uranium Miners ETF | 0.12% | 11,448 | $692K | Reduce -29.7% |
| SLB SLB Ltd. filed as SCHLUMBERGER LTD | 0.12% | 19,697 | $677K | New |
| RXRX Recursion Pharmaceuticals-A | 0.10% | 119,000 | $581K | No change |
| SD Sandridge Energy Inc. | 0.10% | 50,392 | $568K | Add +36.1% |
| AUTL Autolus Therapeutics PLC | 0.09% | 308,837 | $503K | Add +5.0% |
| TSHA Taysha Gene Therapies Inc. | 0.08% | 134,900 | $441K | No change |
| FATE Fate Therapeutics Inc. | 0.08% | 333,219 | $420K | Add +199.9% |
| VAL Valaris Ltd. | 0.07% | 8,315 | $406K | Reduce -39.8% |
| NE Noble Corp. PLC | 0.07% | 14,287 | $404K | No change |
| RIG Transocean Ltd. | 0.06% | 102,000 | $318K | New |
| SBSW Sibanye-Stillwater Ltd.-ADR | 0.05% | 26,232 | $295K | Reduce -22.9% |
| TDW Tidewater Inc. | 0.05% | 5,483 | $292K | Add +2.5% |
| VYGR Voyager Therapeutics Inc. | 0.04% | 45,000 | $210K | Add +78.3% |
Portfolio Sells Q2 2025 → Q3 2025
| SPOT Spotify Technology SA | Reduce -16.7% | 11.92% | −6.38 |
| PLTR Palantir Technologies Inc. Class A | Reduce -42.9% | 6.56% | −3.49 |
| SE Sea Ltd.-ADR | Reduce -23.8% | 5.14% | −1.87 |
| MRNA Moderna Inc. | Reduce -54.6% | 0.22% | −0.42 |
| ACAD Acadia Pharmaceuticals Inc. | Reduce -52.6% | 0.27% | −0.41 |
| CVNA Carvana Co. | Sold out | 0.00% | −0.36 |
| SRPT Sarepta Therapeutics Inc. | Sold out | 0.00% | −0.15 |
| EMX Emx Royalty Corp. | Sold out | 0.00% | −0.12 |
| VAL Valaris Ltd. | Reduce -39.8% | 0.07% | −0.06 |
| PAAS Pan American Silver Corp. | Reduce -37.7% | 0.13% | −0.05 |
| DYN Dyne Therapeutics Inc. | Sold out | 0.00% | −0.05 |
| URNM Sprott Uranium Miners ETF | Reduce -29.7% | 0.12% | −0.04 |
| CRSP Crispr Therapeutics AG | Reduce -10.5% | 0.47% | −0.00 |
| SBSW Sibanye-Stillwater Ltd.-ADR | Reduce -22.9% | 0.05% | −0.00 |
| VZLA Vizsla Silver Corp. | Reduce -18.4% | 0.16% | +0.00 |
| ARQT Arcutis Biotherapeutics Inc. | Reduce -11.2% | 1.04% | +0.01 |
| SHOP Shopify Inc. Class A | Reduce -3.5% | 11.09% | +0.52 |
| IONS Ionis Pharmaceuticals Inc. | Reduce -7.0% | 2.93% | +0.62 |
| ARWR Arrowhead Pharmaceuticals Inc. | Reduce -22.6% | 2.94% | +0.81 |
| QURE Uniqure NV | Reduce -13.7% | 4.05% | +2.70 |
Portfolio Buys Q2 2025 → Q3 2025
| TSLA Tesla Inc. | Add +0.8% | 19.51% | +3.40 |
| AMD Advanced Micro Devices | New | 1.75% | +1.75 |
| LMND Lemonade Inc. | New | 1.40% | +1.40 |
| IREN Iren Ltd. | New | 1.10% | +1.10 |
| ASTS Ast Spacemobile Inc. | New | 0.97% | +0.97 |
| BIIB Biogen Inc. | Add +153.3% | 1.31% | +0.73 |
| ABVX Abivax SA-ADR | New | 0.46% | +0.46 |
| URGN Urogen Pharma Ltd. | Add +82.7% | 0.71% | +0.40 |
| BEAM Beam Therapeutics Inc. | New | 0.27% | +0.27 |
| HIMS Hims & Hers Health Inc. | Add +81.8% | 0.41% | +0.17 |
| RNAM Avidity Biosciences Inc. | Add +15.2% | 0.42% | +0.13 |
| SLB SLB Ltd. | New | 0.12% | +0.12 |
| KRYS Krystal Biotech Inc. | Add +30.6% | 0.39% | +0.11 |
| BNTX Biontech SE-ADR | Add +72.9% | 0.34% | +0.08 |
| SA Seabridge Gold Inc. | Add +10.0% | 0.21% | +0.07 |
| LXEO Lexeo Therapeutics Inc. | Add +7.8% | 0.23% | +0.07 |
| RIG Transocean Ltd. | New | 0.06% | +0.06 |
| FATE Fate Therapeutics Inc. | Add +199.9% | 0.08% | +0.05 |
| WVE Wave Life Sciences Ltd. | Add +25.4% | 0.22% | +0.03 |
| VYGR Voyager Therapeutics Inc. | Add +78.3% | 0.04% | +0.02 |
| SD Sandridge Energy Inc. | Add +36.1% | 0.10% | +0.02 |
| TDW Tidewater Inc. | Add +2.5% | 0.05% | −0.00 |
| PFE Pfizer Inc. | Add +1.9% | 0.17% | −0.03 |
| AUTL Autolus Therapeutics PLC | Add +5.0% | 0.09% | −0.05 |
| ABEV Ambev SA-ADR | Add +12.7% | 0.36% | −0.06 |
| MRK Merck & Co. Inc. | Add +9.0% | 0.97% | −0.07 |
| PRQR Proqr Therapeutics NV | Add +0.0% | 1.91% | −0.25 |
| RARE Ultragenyx Pharmaceutical Inc. | Add +14.4% | 1.57% | −0.41 |
| COIN Coinbase Global Inc. Class A | Add +12.9% | 4.79% | −0.42 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 61 | $544.2M | TSLA, SHOP, AMD, AMZN, IONS |
| Q1 2026 | 60 | $480.3M | TSLA, SHOP, SPOT, PLTR, AMZN |
| Q4 2025 | 57 | $543.1M | TSLA, SHOP, SPOT, PLTR, AMZN |
| Q3 2025 | 59 | $556.3M | TSLA, SPOT, SHOP, PLTR, AMZN |
| Q2 2025 | 55 | $463.5M | SPOT, TSLA, SHOP, PLTR, AMZN |
| Q1 2025 | 56 | $383.6M | SPOT, TSLA, SHOP, PLTR, SE |
| Q4 2024 | 59 | $437.0M | TSLA, SPOT, SHOP, AMZN, PLTR |
| Q3 2024 | 82 | $402.0M | TSLA, SPOT, SHOP, AMZN, ASTS |
| Q2 2024 | 85 | $358.2M | TSLA, SPOT, AMZN, SHOP, SNOW |
| Q1 2024 | 75 | $342.7M | SPOT, SHOP, TSLA, AMZN, SNOW |